EXENS — Exosens SAS Cashflow Statement
0.000.00%
Last trade - 00:00- €3.47bn
- €3.63bn
- €468.19m
Annual cashflow statement for Exosens SAS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -149 | 11.2 | 18.4 | 34.1 | 70.2 |
| Depreciation | |||||
| Non-Cash Items | 182 | 17.2 | 29.7 | 45.2 | 36.7 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.18 | -1.51 | -28.5 | -15.2 | -39 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 42.7 | 47.5 | 50.5 | 98.7 | 107 |
| Capital Expenditures | -19.6 | -21.8 | -30.9 | -40 | -50.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.67 | -33.7 | -68.7 | -31.5 | -71.1 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -21.3 | -55.5 | -99.6 | -71.4 | -121 |
| Financing Cash Flow Items | -13.4 | -13.8 | -20.3 | -31 | -12.7 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -36.8 | 20.3 | 35.5 | 76.9 | -25.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -15.2 | 12.4 | -13.5 | 105 | -39.8 |